home

House Comm. Seeks Epi Pen Documents, Generic Version Announced

By Jeralyn, Section Other Politics
Posted on Mon Aug 29, 2016 at 02:33:58 PM EST
Tags: (all tags)
Share This: Digg! StumbleUpon del.icio.us reddit reddit

The House Committee on Oversight and Government Reform has requested Mylan CEO Heather Bresch to produce documents and communications about the price increase of Epi Pen.

Mylan today announced it will sell a $300.00 generic version.

Almost every news story has an auto-play video which I won't link to. It's taking more and more time to find articles without video. It is such a waste of time and it really takes a lot of the fun out of blogging.

< Sunday Open Thread | Weiner and Clinton Aide Huma Abedin Split >

  • The Online Magazine with Liberal coverage of crime-related political and injustice news

  • Contribute To TalkLeft


    • Display: Sort:
    House Comm. Seeks Epi Pen Documents, Generic Version Announced | 45 comments (45 topical)

    Readers Must Login or Create an Account to Comment

    Generic from Mylan (1.00 / 2) (#1)
    by Abdul Abulbul Amir on Tue Aug 30, 2016 at 02:35:40 PM EST
    How interesting.  There are more than a half dozen competitive products available in Europe, but no effective competition in the US.

    Perhaps some of those potential competitors should take a lesson from the Mylan CEO and pony up come cash for the Clinton foundation.

    Apart from your specious ... (none / 0) (#2)
    by Yman on Tue Aug 30, 2016 at 07:47:49 PM EST
    ... slur by implication, you realize that your basic premise is a lie, right?

    Might want to check that kinda thing before you start making silly accusations with no evidence to support them.

    Parent

    Europe (none / 0) (#3)
    by TrevorBolder on Wed Aug 31, 2016 at 04:32:37 PM EST
    has multiple versions of a epinephrine injector, thus a lower price.
    The FDA has had numerous applications in the last 5 years and has kept them jumping through hoops.
    There is one competitor , I believe in the US, but Congress passed a law, if the Dr prescribes Epipen, which most of them do, like Kleenex is for tissues, the pharmacist cannot prescribe the cheaper generic version.

    Parent
    Consumer Reports (none / 0) (#4)
    by TrevorBolder on Wed Aug 31, 2016 at 04:36:18 PM EST
    http://tinyurl.com/gt5t35k

    Parent
    That's great (none / 0) (#5)
    by Yman on Wed Aug 31, 2016 at 07:38:51 PM EST
    But irrelevant to his slur/specious claims.  Heather Dresch did not donate to the Clinton Foundation and her non-existent donation has nothing to do with the fact that Mylan has a large majority of the US market.

    BTW - All drug and medical device manufacturers have to "jump through hoops".  It's called making sure new drugs and delivery devices are safe and effective.  But the actual reasons that two (as opposed to "numerous") competitors were rejected is because of:  1)  Sanofi's product was recalled because of dosage problems and 2) Teva's generic version in November 2015 and further when Teva's generic competitor was rejected by the FDA in March due to "major deficiencies".

    Parent

    I thought the (none / 0) (#6)
    by TrevorBolder on Wed Aug 31, 2016 at 08:35:40 PM EST
    Basic premise was this
    How interesting.  There are more than a half dozen competitive products available in Europe, but no effective competition in the US.

    So why does europe have 6 choices, and the US only 2?

    Is Europe 's health care system  deficient as to protecting their citizens health,
    Or is just too difficult to get anything approved by the FDA. I understand Mylan is a major major lobbyist in DC

    Parent

    You were replying to my post, right? (none / 0) (#7)
    by Yman on Wed Aug 31, 2016 at 09:29:26 PM EST
    Because my point was very clear, and has nothing to do with your "questions".  But maybe you should research the issue if that's what you're concerned about.  Might help with your false assumptions.

    BTW - All drug manufacturers are major lobbyists, unless you're trying to suggest sone thing more, like Abdul.

    Parent

    I read several articles (none / 0) (#8)
    by TrevorBolder on Thu Sep 01, 2016 at 05:06:08 AM EST
    yesterday regarding this. Many stated that access for American patients is stifled by the FDA,
    the lobbying created the law that Dr's in most states have to prescribe Epipen if that what the Dr writes on the prescription, despite their being  a cheaper generic version.And Dr's write Epipen like people refer to tissues as Kleenex.
    As to the product recalled because of dosage problems, Epipen had the same issues at the same percentages.

    So you are saying that the European health care system is just more cavalier with the health of its citizens then


    Parent

    I have no idea what articles you read (none / 0) (#9)
    by Yman on Thu Sep 01, 2016 at 06:26:00 AM EST
    I don't really care.  Nor do I care about your latest link-free, evidence-free claims.  They're not relevant to my point, which was Abdul's specious/false slurs regarding the Clinton foundation and Mylar's CEO.  So if you decide you want to respond to my post, perhaps you should try to address my point.  Otherwise, I'll continue to ignore your irrelevant claims.

    Parent
    NPR (none / 0) (#10)
    by TrevorBolder on Thu Sep 01, 2016 at 04:06:09 PM EST
    Makes the case, there are many questions, not very convincing answers .
    Big differences in Europe and the USA as far as generic drug options,
    The Epipen just brought the issue to the forefront.
    That was the most important aspect of the post, something which actually affects everyone here.

    The little throwaway line regarding Mylar and the Clinton Foundation probably had its genesis because of their prior history of working together,

    The Clinton Foundation partnered with Mylan at a time when it was raising prices on the EpiPen, which had been distributed by Merck.
    The company partnered in 2009 with the Clinton Foundation to provide a lower-cost alternative for four HIV drugs. Clinton Foundation records show that Mylan has donated between $100,000 and $250,000 to the Foundation.


    Parent
    Not my post (none / 0) (#11)
    by Yman on Thu Sep 01, 2016 at 04:11:41 PM EST
    If you think it was the "most important aspect of the post," respond to the OP.  The most important aspect of my post - the one you responded to - was very clear.   The false accusations and smears against the Clinton Foundation.  It was the focus of Abdul's post and the one I called him on.   Your "throwaway line" about the foundation is no better.

    Parent
    Mylan has a near monopoly (none / 0) (#13)
    by Abdul Abulbul Amir on Fri Sep 02, 2016 at 03:30:28 PM EST

    due to the FDA

    Parent
    They have a "near monopoly" (none / 0) (#19)
    by Yman on Fri Sep 02, 2016 at 07:36:46 PM EST
    ... because the approval process can take a long time and the other companies haven't managed to get their acts together.

    Parent
    They (none / 0) (#20)
    by TrevorBolder on Fri Sep 02, 2016 at 07:56:35 PM EST
    Seem to get it done in Europe though.

    Hmmm, FDA has no jurisdiction in Europe...Do they?

    Parent

    No kidding (none / 0) (#22)
    by Yman on Sat Sep 03, 2016 at 06:31:25 AM EST
    The problem for the drug companies is that they when they make an application for a drug/device in this country, they have to abide by our laws and standards.  

    Hmmmmm ....  If you prefer Europe's laws/standards, you'll need to speak with Congress.  But, hey ... congrats on figuring out the FDA doesn't have jurisdiction in Europe.

    Parent

    The obvious (none / 0) (#23)
    by TrevorBolder on Sat Sep 03, 2016 at 09:16:32 AM EST
    Well, to most of us,

    The goal is to get more and cheaper generics available to the public.

    Europe seems to have done that, without mass deaths occurring from the release of "deadly inferior generics" upon the public.

    And the obvious question, why is the FDA preventing the release of generics in the US.
    Lobbying money having its expected results is a obvious answer,
    Since Europe seems to be getting it done

    Parent

    "Obvious" - heh (none / 0) (#24)
    by Yman on Sat Sep 03, 2016 at 09:25:32 AM EST
    And the obvious question, why is the FDA preventing the release of generics in the US.  Lobbying money having its expected results is a obvious answer, Since Europe seems to be getting it done

    The last resort of someone with no evidence to support their silly smears.  Not to mention those who pretend to speak for "most of us".

    Heh.

    Parent

    Well (none / 0) (#25)
    by TrevorBolder on Sat Sep 03, 2016 at 11:07:21 AM EST
    The last resort of someone with no evidence to support their silly smears.

    Basically the NPR piece I linked to shows that Europe has a infinitely smaller waiting list for generics to get approved than here.
    That is evidence. Yes, it is a obvious question that should be explored. And based on the US system and evidence of successful lobbying in this country, yea, it is a good possibility. Either that or the FDA is just incompetent compared to their European counterparts

    You , on the other hand, have produced nothing to warrant your dismissals.